2012-2015年南京市属31家二、三级医疗卫生机构基本药物采购配备分析

发布时间：2019-01-22 17:37

【摘要】：目的:为制定促进基本药物在二、三级医疗卫生机构推广应用的政策提供依据。方法:调取2012年1月-2015年12月南京市属所有的共计31家二、三级医疗卫生机构的药品采购入库数据,利用Excel 2010和SPSS 20.0软件汇总、统计和分析基本药物的采购金额和配备数量情况。结果:2012-2015年,31家医疗卫生机构基本药物采购金额占药品总采购金额的比例(简称"基本药物采购金额占比")平均分别为18.33%、18.56%、17.19%、17.53%,国家基本药物采购金额占基本药物采购金额的比例(简称"国家基本药物采购金额占比")平均分别为31.14%、29.40%、25.69%、25.79%,配备的基本药物通用名数平均分别为189.84、205.58、210.26、206.65个;其中,2014年基本药物采购金额占比、国家基本药物采购金额占比均较2013年显著降低(P0.05),2013年配备的基本药物通用名数较2012年显著增加(P0.05)。各年度二级医疗卫生机构基本药物采购金额占比均显著高于三级医疗卫生机构;综合医院基本药物采购金额占比均显著高于专科医院,配备的基本药物通用名数均显著高于中医院和专科医院;下辖社区卫生服务中心的二级医疗卫生机构基本药物采购金额占比均显著高于未下辖社区卫生服务中心的二级医疗卫生机构,差异均有统计学意义(P0.05)。各年度综合医院基本药物采购金额占比与药品总采购金额均具有负相关性(P0.05);所有医疗卫生机构配备的基本药物通用名数与全部药品通用名数均具有正相关性(P0.05)。结论:2012-2015年南京市二、三级医疗卫生机构基本药物采购金额占比、国家基本药物采购金额占比及配备的基本药物通用名数差异较大,数值普遍较低,除个别医疗卫生机构外绝大多数没有达到江苏省卫生计生委的要求。医疗卫生机构的级别、类型、药品采购配备规模及是否下辖社区卫生服务中心均可能对其基本药物采购配备产生影响。
[Abstract]:Objective: to provide the basis for the policy of promoting the application of essential drugs in the secondary and tertiary medical and health institutions. Methods: from January 2012 to December 2015, the data of drug purchase from 31 second and third level medical and health institutions in Nanjing were collected and collected by Excel 2010 and SPSS 20.0 software. Statistics and analysis of the purchase amount and quantity of essential drugs. Results: from 2012 to 2015, the proportion of essential drugs purchased from 31 medical and health institutions to the total amount of drugs purchased (referred to as "the proportion of essential drug purchases") was 18.33 and 18.566.19 respectively. The proportion of the amount of essential drugs purchased by the State to the amount of essential drugs purchased (referred to as "the proportion of the amount of essential drugs purchased by the State") is 31.14% and 29.40% respectively. The average number of generic names of essential drugs was 189.84205.58210.26206.65; Among them, the proportion of essential drugs purchase amount in 2014 was significantly lower than that in 2013 (P0.05), and the number of general names of essential drugs in 2013 significantly increased compared with 2012 (P0.05). The proportion of the purchase amount of essential drugs in the second-level medical and health institutions was significantly higher than that in the third-level medical and health institutions. The proportion of purchase amount of essential drugs in general hospitals was significantly higher than that in specialized hospitals, and the number of generic names of essential drugs in general hospitals was significantly higher than that in Chinese medicine hospitals and specialized hospitals. The proportion of the purchase amount of essential drugs in the second level medical and health institutions under the jurisdiction of the community health service center was significantly higher than that in the second level of the community health service center without jurisdiction, and the difference was statistically significant (P0.05). There was a negative correlation between the proportion of purchase amount of essential drugs in general hospitals and the total purchase amount of drugs (P0.05). There was a positive correlation between the number of generic names of essential drugs and the number of generic names of all medicines in all medical and health institutions (P0.05). Conclusion: from 2012 to 2015, the proportion of purchase amount of essential drugs in the second and third level medical and health institutions in Nanjing City was higher, and the proportion of national essential drugs purchase amount and the number of general names of the essential drugs provided were quite different, and the values were generally lower. In addition to individual medical and health institutions, the vast majority did not meet the requirements of the Jiangsu Provincial Health and Family Planning Commission. The level and type of medical and health institutions, the size of drug procurement equipment and whether the community health service centers are under the jurisdiction may have an impact on the procurement of essential drugs.
【作者单位】：南京市药品集中采购托管中心;南京医科大学附属南京医院;苏州大学政治与公共管理学院;南京药学会;
【基金】：江苏省药学会-奥赛康医院药学基金立项课题(No.苏药会字[2014]78号) 南京市科协软科学研究项目(No.NJKX2016RKX-03) 南京药学会-常州四药医院药学科研基金项目(No.2014YX015)
【分类号】：R95

【参考文献】